Allergan
FDA Approves New Indication for Vraylar
Herbert Meltzer, MD: “Schizophrenia is one of the most challenging mental health disorders to manage, ...
NOVEMBER 15, 2017
The ‘Perfect Storm’ That Hampers Stewardship
Antimicrobial resistance continues to present a challenge to patient care for gram-negative bacterial infections, ...
NOVEMBER 14, 2017
Resistance to Colistin Low, but Geographically Dispersed
While Colistin still is very effective at eliminating CRE, resistance has been found to be spread across the ...
JUNE 22, 2017
FDA Warns Against Use of Viberzi for Patients Without Gallbladder
The FDA reported that eluxadoline (Viberzi, Allergan) has been linked to severe pancreatitis and death in patients ...
MARCH 16, 2017
FDA Approves Noctiva for Nocturnal Polyuria
The FDA approved Allergan's Noctiva nasal spray for adults who awaken at least twice per night to urinate due to ...
MARCH 7, 2017
